United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Mar 31, 2026 · Filed Apr 2, 2026

On Mar 31, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$585.76 for US$5.56M under a trading plan, leaving 40,513 shares. Filed Apr 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$585.76 average (US$574.55 to US$594.11)
Value
US$5.56M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common StockOption exercise9,500US$146.0350,013Direct
Mar 31, 2026Common StockSale80US$574.5549,933Direct
Mar 31, 2026Common StockSale160US$577.5449,773Direct
Mar 31, 2026Common StockSale240US$580.0849,533Direct
Mar 31, 2026Common StockSale503US$581.1049,030Direct
Mar 31, 2026Common StockSale805US$582.1948,225Direct
Mar 31, 2026Common StockSale1,391US$583.0846,834Direct
Mar 31, 2026Common StockSale980US$584.0445,854Direct
Mar 31, 2026Common StockSale1,161US$585.0044,693Direct
Mar 31, 2026Common StockSale886US$586.1443,807Direct
Mar 31, 2026Common StockSale467US$587.3743,340Direct
Mar 31, 2026Common StockSale567US$588.3842,773Direct
Mar 31, 2026Common StockSale600US$589.4042,173Direct
Mar 31, 2026Common StockSale760US$590.3641,413Direct
Mar 31, 2026Common StockSale700US$593.1340,713Direct
Mar 31, 2026Common StockSale200US$594.1140,513Direct

Source

View original at SEC

Related